This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Msd International Gmbh. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Steven J Brenek: Innovator in SGLT2 Inhibitor Development
Introduction
Steven J Brenek is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sodium-glucose transporter 2 (SGLT2) inhibitors. His work is essential in advancing treatments for various medical conditions.
Latest Patents
Steven J Brenek holds 1 patent for his invention titled "Methods for preparing SGLT2 inhibitors." This patent relates to innovative methods for preparing a sodium-glucose transporter 2 (SGLT2) inhibitor, a cocrystalline SGLT2, and (S)-5-oxopyrrolidine-2-carboxylic acid (L-PGA) complex. The invention also includes intermediates that are useful in the preparation of the SGLT2 inhibitor.
Career Highlights
Steven is currently employed at MSD International GmbH, where he continues to contribute to the pharmaceutical industry. His expertise in the development of SGLT2 inhibitors showcases his commitment to improving healthcare solutions.
Collaborations
Steven has collaborated with notable colleagues, including Stephane Caron and Jade D Nelson. Their teamwork enhances the innovative processes within their projects.
Conclusion
Steven J Brenek is a distinguished inventor whose work in SGLT2 inhibitors is paving the way for advancements in medical treatments. His contributions are vital to the ongoing evolution of pharmaceutical innovations.